apt

Encoding, Consolidation, and Renormalization in Depression: Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects [Review Articles]

Recent studies have strived to find an association between rapid antidepressant effects and a specific subset of pharmacological targets and molecular pathways. Here, we propose a broader hypothesis of encoding, consolidation, and renormalization in depression (ENCORE-D), which suggests that, fundamentally, rapid and sustained antidepressant effects rely on intrinsic homeostatic mechanisms evoked as a response to the acute pharmacological or physiologic effects triggered by the treatment. We review evidence that supports the notion that various treatments with a rapid onset of action, such as ketamine, electroconvulsive therapy, and sleep deprivation, share the ability to acutely excite cortical networks, which increases synaptic potentiation, alters patterns of functional connectivity, and ameliorates depressive symptoms. We proceed to examine how the initial effects are short-lived and, as such, require both consolidation during wake and maintenance throughout sleep to remain sustained. Here, we incorporate elements from the synaptic homeostasis hypothesis and theorize that the fundamental mechanisms of synaptic plasticity and sleep, particularly the homeostatic emergence of slow-wave electroencephalogram activity and the renormalization of synaptic strength, are at the center of sustained antidepressant effects. We conclude by discussing the various implications of the ENCORE-D hypothesis and offer several considerations for future experimental and clinical research.

Significance Statement

Proposed molecular perspectives of rapid antidepressant effects fail to appreciate the temporal distribution of the effects of ketamine on cortical excitation and plasticity as well as the prolonged influence on depressive symptoms. The encoding, consolidation, and renormalization in depression hypothesis proposes that the lasting clinical effects can be best explained by adaptive functional and structural alterations in neural circuitries set in motion in response to the acute pharmacological effects of ketamine (i.e., changes evoked during the engagement of receptor targets such as N-methyl-D-aspartate receptors) or other putative rapid-acting antidepressants. The present hypothesis opens a completely new avenue for conceptualizing and targeting brain mechanisms that are important for antidepressant effects wherein sleep and synaptic homeostasis are at the center stage.




apt

A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials

Background and objectives

Tolvaptan is approved to slow kidney function decline in adults with autosomal dominant polycystic kidney disease (ADPKD) at risk of rapid progression. Because in vitro studies indicated that the tolvaptan oxobutyric acid metabolite inhibits organic anion–transporting polypeptide (OATP)1B1 and OATP1B3, United States prescribing information advises avoiding concurrent use with OATP1B1/1B3 substrates, including hepatic hydroxymethyl glutaryl–CoA reductase inhibitors (statins). This post hoc analysis of the pivotal phase 3 tolvaptan trials (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes [TEMPO] 3:4 trial [NCT00428948] and Replicating Evidence of Preserved Renal Function: an Investigation of Tolvaptan Safety and Efficacy in ADPKD [REPRISE] trial [NCT02160145]) examined the safety of concurrent tolvaptan/statin use.

Design, setting, participants, & measurements

The trials randomized a combined total of 2815 subjects with early- to late-stage ADPKD to tolvaptan (n=1644) or placebo (n=1171) for 3 years (TEMPO 3:4) and 1 year (REPRISE). Statin use was unrestricted, and 597 subjects (21.2% overall; 332 [20.2%] tolvaptan, 265 [22.6%] placebo) received statins. Statin use (duration, dose change, statin change, permanent discontinuation), incidences of statin-related adverse events, and hepatic transaminase elevations were determined for subjects who received tolvaptan+statin, placebo+statin, tolvaptan alone, and placebo alone.

Results

No differences in statin use parameters between tolvaptan- and placebo-treated subjects were observed. No statistically significant increases in commonly reported statin-related adverse events (e.g., musculoskeletal disorders, gastrointestinal symptoms) were seen between subjects receiving tolvaptan+statin and placebo+statin. For example, in TEMPO 3:4, frequencies were 5.4% and 7.8%, respectively, for myalgia (difference –2.4%; 95% confidence interval, –11.2% to 6.4%) and 9.3% and 7.8%, respectively, for abdominal pain (difference 1.5%; –7.9% to 10.9%). In an analysis that excluded participants concurrently using allopurinol, the frequency of alanine transaminase or aspartate transaminase >3x upper limit of normal in the pooled study populations was 3.6% for the tolvaptan+statin group and 2.3% for the placebo+statin group (difference 1.4%; –2.0% to 4.7%).

Conclusions

Tolvaptan has been used safely in combination with statins in clinical trials.

Podcast

This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_04_06_CJN.08170719.mp3




apt

IL1{alpha} Antagonizes IL1{beta} and Promotes Adaptive Immune Rejection of Malignant Tumors

We assessed the contribution of IL1 signaling molecules to malignant tumor growth using IL1β–/–, IL1α–/–, and IL1R1–/– mice. Tumors grew progressively in IL1R–/– and IL1α–/– mice but were often absent in IL1β–/– mice. This was observed whether tumors were implanted intradermally or injected intravenously and was true across multiple distinct tumor lineages. Antibodies to IL1β prevented tumor growth in wild-type (WT) mice but not in IL1R1–/– or IL1α–/– mice. Antibodies to IL1α promoted tumor growth in IL1β–/– mice and reversed the tumor-suppressive effect of anti-IL1β in WT mice. Depletion of CD8+ T cells and blockade of lymphocyte mobilization abrogated the IL1β–/– tumor suppressive effect, as did crossing IL1β–/– mice to SCID or Rag1–/– mice. Finally, blockade of IL1β synergized with blockade of PD-1 to inhibit tumor growth in WT mice. These results suggest that IL1β promotes tumor growth, whereas IL1α inhibits tumor growth by enhancing T-cell–mediated antitumor immunity.




apt

Pregnancy-adapted YEARS algorithm: can YEARS do more for pregnant women?

Venous thromboembolism (VTE), as a term that encompasses pulmonary embolism (PE) and deep vein thrombosis (DVT), is one of the leading causes of maternal morbidity and mortality [1], especially in developed countries, where PE takes second place after complications of hypertensive disorders [2]. When compared to non-pregnant women of similar age, pregnant women have an approximately four to five times higher risk of VTE [3], with an incidence of 1 in 1000 pregnancies [4]. Approximately 20–25% of VTE cases are caused by PE and 75–80% of cases are caused by DVT [5]. About 60% of DVT occurs antepartum, with the highest risk of antepartum pregnancy-associated VTE being in the third trimester.However, about 60% of PE occurs postpartum [3].




apt

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

Purpose:

Currently, an optimal therapeutic strategy comprising molecularly targeted agents for treating EGFR-mutated non–small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib is not available. Therefore, the initial therapeutic intervention is crucial for the prolonged survival of these patients. The activation of anexelekto (AXL) signaling is known to be associated with intrinsic and acquired resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs). In this study, we investigated the best therapeutic strategy to combat AXL-induced tolerance to EGFR-TKIs using the novel AXL inhibitor ONO-7475.

Experimental Design:

We examined the efficacy of ONO-7475 in combination with EGFR-TKIs in EGFR-mutated NSCLC cells using in vitro and in vivo experiments. We investigated the correlation between AXL expression in tumors and clinical outcomes with osimertinib for EGFR-mutated NSCLC patients with acquired resistance to initial EGFR-TKIs.

Results:

ONO-7475 sensitized AXL-overexpressing EGFR-mutant NSCLC cells to the EGFR-TKIs osimertinib and dacomitinib. In addition, ONO-7475 suppressed the emergence and maintenance of EGFR-TKI–tolerant cells. In the cell line–derived xenograft models of AXL-overexpressing EGFR-mutated lung cancer treated with osimertinib, initial combination therapy of ONO-7475 and osimertinib markedly regressed tumors and delayed tumor regrowth compared with osimertinib alone or the combination after acquired resistance to osimertinib. AXL expression in EGFR-TKI refractory tumors did not correlate with the sensitivity of osimertinib.

Conclusions:

These results demonstrate that ONO-7475 suppresses the emergence and maintenance of tolerant cells to the initial EGFR-TKIs, osimertinib or dacomitinib, in AXL-overexpressing EGFR-mutated NSCLC cells, suggesting that ONO-7475 and osimertinib is a highly potent combination for initial treatment.




apt

Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model [Experimental Therapeutics]

Tedizolid (TZD) and daptomycin (DAP) were assessed in a rat endocarditis model against Enterococcus faecalis, Enterococcus faecium (resistant to vancomycin and ampicillin), and Staphylococcus aureus. As a monotherapy, TZD for 5 days was not effective in a comparison with no-treatment controls, while DAP for 5 days was significantly effective against these bacteria. Step-down therapy (DAP for 3 days followed by TZD for 2 days) was as effective as DAP for 5 days and was comparable to 3 days of DAP plus ceftriaxone against all bacteria and to 3 days of DAP plus gentamicin against E. faecalis OG1RF.




apt

Impact of Daptomycin Dose Exposure Alone or in Combination with {beta}-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model [Susceptibility]

Enterococcus faecium strains are commonly resistant to vancomycin and β-lactams. In addition, E. faecium often causes biofilm-associated infections and these infections are difficult to treat. In this context, we investigated the activity of dosing regimens using daptomycin (DAP) (8, 10, 12, and 14 mg/kg of body weight/day) alone and in combination with ceftaroline (CPT), ampicillin (AMP), ertapenem (ERT), and rifampin (RIF) against 2 clinical strains of biofilm-producing vancomycin-resistant Enterococcus faecium (VREfm), namely, strains S447 and HOU503, in an in vitro biofilm model. HOU503 harbors common LiaS and LiaR substitutions, whereas S447 lacks mutations associated with the LiaFSR pathway. MIC results demonstrated that both strains were susceptible to DAP and resistant to CPT, AMP, ERT, and RIF. The 168-h pharmacokinetic/pharmacodynamic (PK/PD) CDC biofilm reactor models (simulating human antibiotic exposures) were used with titanium and polyurethane coupons to evaluate the efficacy of antibiotic combinations. DAP 12 and 14 achieved bactericidal activity against S447 but lacked such effect against HOU503. Addition of ERT and RIF enhanced DAP activity, allowing DAP 8 and 10 plus ERT or RIF to produce bactericidal activity against both strains at 168 h. While DAP 8 and 10 plus CPT improved killing, they did not reach bactericidal reduction against S447. Combination of AMP, CPT, ERT, or RIF resulted in enhanced and bactericidal activity for DAP against HOU503 at 168 h. Our data provide further support for the use of combinations of DAP with AMP, ERT, CPT, and RIF in infections caused by biofilm producing VREfm. Further research involving DAP combinations against biofilm-producing enterococci is warranted.




apt

[Molecular Pathology] Pharmacologic Approaches for Adapting Proteostasis in the Secretory Pathway to Ameliorate Protein Conformational Diseases

Maintenance of the proteome, ensuring the proper locations, proper conformations, appropriate concentrations, etc., is essential to preserve the health of an organism in the face of environmental insults, infectious diseases, and the challenges associated with aging. Maintaining the proteome is even more difficult in the background of inherited mutations that render a given protein and others handled by the same proteostasis machinery misfolding prone and/or aggregation prone. Maintenance of the proteome or maintaining proteostasis requires the orchestration of protein synthesis, folding, trafficking, and degradation by way of highly conserved, interacting, and competitive proteostasis pathways. Each subcellular compartment has a unique proteostasis network compromising common and specialized proteostasis maintenance pathways. Stress-responsive signaling pathways detect the misfolding and/or aggregation of proteins in specific subcellular compartments using stress sensors and respond by generating an active transcription factor. Subsequent transcriptional programs up-regulate proteostasis network capacity (i.e., ability to fold and degrade proteins in that compartment). Stress-responsive signaling pathways can also be linked by way of signaling cascades to nontranscriptional means to reestablish proteostasis (e.g., by translational attenuation). Proteostasis is also strongly influenced by the inherent kinetics and thermodynamics of the folding, misfolding, and aggregation of individual proteins, and these sequence-based attributes in combination with proteostasis network capacity together influence proteostasis. In this review, we will focus on the growing body of evidence that proteostasis deficits leading to human pathology can be reversed by pharmacologic adaptation of proteostasis network capacity through stress-responsive signaling pathway activation. The power of this approach will be exemplified by focusing on the ATF6 arm of the unfolded protein response stress responsive-signaling pathway that regulates proteostasis network capacity of the secretory pathway.




apt

Saigon Royal's apt for rent officetel, 1-2-3 bedrooms fully furnished, District 4 with good price.

Specializing in renting many Saigon Royal officetel apartments, a prime location right at the foot of Mong bridge, only 1 minute to District 1, high-class facilities, luxurious reception hall, can work and stay overnight.Contact: 0908.888.683 James Email: johny220116@gmail.com* P...




apt

Tech leaders talk about adapting to COVID-19

Windsor’s tech community came together Friday to share all the ways they are making the most of the COVID-19 pandemic. During an online event, leaders of seven local tech companies explained how they are dealing with, and capitalizing on the current pandemic. From the ability to scan facial temperatures, checking your blood for COVID-19 immunity, […]




apt

Captured carbon dioxide could be used to help recycle batteries

We have to capture carbon dioxide to slow climate change, but instead of simply burying it we could first use it to extract useful metals from old electrical equipment




apt

You, in your bedroom, with your laptop. That's not the future of film festivals | Peter Bradshaw

In the wake of Covid-19, We Are One: A Global Film Festival is taking the experience online. But cinema is a bigger encounter

Every year, at Cannes (and other festivals) there’s a plaintive argument about what Cannes (or other festivals) are really all “about”. Some Savonarola-type person will dash the glass of rosé out of your hand, throw your canape into the Med and tell you Cannes is not about red-carpet narcissism, not about stars preening in the flashbulb glare of celeb-worship, not about L’Oréal sponsorship, not about getting drunk at a million late-night parties. It’s about the movies, about cinema itself.

Of course. And that’s what the new Covid-19-related We Are One: A Global Film Festival appears to offer: the 10-day online festival, beginning 29 May, curated by Jane Rosenthal of the Tribeca film festival, featuring arthouse films (though not the big-ticket Hollywood items) from Cannes, Venice, Berlin and many more, streaming for free in return for an optional donation to the World Health Organization’s Covid-19 fund. So there you have it. A festival with all the frills and extras and flummeries stripped away. Just you, in your bedroom, with your laptop, communing with cinema. Isn’t that what it’s all about?

Continue reading...




apt

Raptorial Dinosaurs Did Not Hunt in Coordinated Packs, Paleontologists Say

An analysis of the fossilized teeth of Deinonychus antirrhopus, a species of wolf-sized dromaeosaurid dinosaur that lived between 115 and 108 million years ago (Cretaceous period) in what is now the United States, adds to the growing evidence that this and other raptors were not complex social hunters by modern mammalian standards. The image of [...]




apt

‘Resident Evil: The Final Chapter,’ ‘Gold,’ ‘A Dog’s Purpose’: Review Revue

What film critics have to say about this week's new releases.




apt

Ariana Grande and Justin Bieber capture lockdown mood in star-studded Stuck With U video

Stuck With U also saw Ariana confirm she's got a new beau.




apt

Flies sleep when need arises to adapt to new situations

Researchers have found that flies sleep more when they can't fly, possibly because sleeping helps them adapt to a challenging new situation.




apt

New coronavirus adapts to populations; vaccine works in monkeys

The following is a brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.




apt

The moment coronavirus infects a healthy cell captured under microscope

Read our live updates on coronavirus HERE Coronavirus: The symptoms




apt

War veteran Captain Tom Moore, 99, raises over £7m for NHS by walking lengths of his garden

UPDATE: War veteran, 99, hits £9 million for NHS as Matt Hancock calls him an 'inspiration'




apt

How to donate to Captain Tom Moore's NHS fundraiser

Coronavirus: the symptoms Read our live updates here




apt

Captain Tom Moore says knighthood would be 'marvellous' as campaign for honour continues

Read our live coronavirus updates HERE




apt

War veteran Captain Tom Moore, 99, hits £14 million for NHS as Matt Hancock calls him an 'inspiration'

Follow our live Covid-19 updates HERE Coronavirus: The symptoms




apt

Captain Tom Moore completes final fundraising lap for NHS as donations soar past £12m

Follow our live coronavirus updates HERE Coronavirus: The symptoms




apt

Royals send thank you letters to hero Captain Tom Moore, 99, after fundraiser for NHS hits £15 million

The Duke of Cambridge and his stepmother the Duchess of Cornwall have both written to Captain Tom Moore, 99, to congratulate him on smashing his NHS fundraising target.




apt

War veteran Captain Tom Moore, 99, raises £16m for NHS as Boris Johnson looks at ways to honour 'heroic efforts'

Follow our live coronavirus updates HERE Coronavirus: The symptoms




apt

War veteran Captain Tom Moore, 99, says he'd be 'amazed' to meet Queen amid petitions for knighthood

Live coronavirus updates here




apt

NHS staff and Carrie Symonds thank 'inspirational' war veteran Captain Tom Moore during weekly applause

NHS staff and Carrie Symonds are among those who have thanked "inspirational" war veteran Captain Tom Moore during the weekly clap for carers.




apt

Captain Tom Moore hits £18 million in NHS fundraiser as Prince William donates to cause

Read our live coronavirus updates HERE




apt

Pensioner, 90, attempting to climb height of Suilven mountain on stairs raises £100,000 after being inspired by Captain Tom Moore

Read our coronavirus live updates HERE Coronavirus: The symptoms




apt

Lower Clapton crash: Motorcyclist dies after crash on busy road in north-east London

A motorcyclist has died after a crash on a busy road in north-east London.




apt

War veteran Captain Tom Moore, 99, raises more than £20 million for NHS during coronavirus crisis

War veteran Captain Tom Moore has now raised more than £20 million to help the NHS during the coronavirus crisis - twenty thousand times his initial target.




apt

War veteran Captain Tom Moore, 99, to be 'guest of honour' at new Nightingale Hospital opening

National treasure Captain Tom Moore, 99, will help open the newest NHS Nightingale hospital as a "guest of honour."




apt

Hero Captain Tom Moore shares message of hope: We will get through this and come out stronger

He has raised more than £25 million




apt

Prince Harry hails 'wonderfully British response' to Covid-19 and gives shout-out to 'amazing' Captain Tom Moore

The Duke of Sussex has said he's "incredibly proud" of the British public as the country rallies together to tackle the coronavirus crisis.




apt

Fundraising hero Captain Tom Moore's charity cover on course for number one

Captain Tom Moore and Michael Ball are on course to score a number one single for their cover of You'll Never Walk Alone.




apt

Fundraising hero Captain Tom Moore to open NHS Nightingale hospital in Yorkshire

New field hospital in Harrogate to provide 500 extra beds for Covid-19 patients




apt

Captain Tom Moore praises 'magnificent' NHS as he opens Nightingale hospital in Yorkshire

Fundraising hero Captain Tom Moore praised the NHS for doing a "magnificent job" as he opened Yorkshire's new Nightingale hospital via video link today.




apt

NHS fundraising hero Captain Tom Moore sent 'tens of thousands' of birthday cards

War veteran Captain Tom Moore, who has raised £28 million for the NHS by walking lengths of his garden, has been sent tens of thousands of cards ahead of his 100th birthday.




apt

Captain Tom Moore given Pride of Britain award as he urges fans to donate 'lovely' gifts to care homes

War veteran Captain Tom Moore, who has raised £28 million for the NHS by walking lengths of his garden, has been given a Pride of Britain award.




apt

Captain Tom Moore delighted after The Weeknd backs veteran in chart battle - but appears not to know who singer is

War veteran Captain Tom Moore, who has raised millions for the NHS by walking lengths of his garden, has thanked The Weeknd for his "kind gesture" after the singer urged his fans to support the 99-year-old's single.




apt

Navy submarine captain investigated over 'rave barbecue' amid coronavirus lockdown

The Royal Navy is investigating reports that a nuclear submarine crew held a party after returning to their UK base while the rest of the country was under coronavirus lockdown.




apt

Stunning images captured by the Hubble Telescope's to mark its 30th anniversary

These stunning images show some of the mesmerising sights captured by the Hubble Telescope during its 30 years of observing space.




apt

Hero Captain Tom Moore 'shortlisted for honour' after raising £28m for NHS workers




apt

Captain Tom Moore gets special postmark on UK mail to celebrate his 100th birthday

All mail sent this week in the UK will be stamped with a special postmark to celebrate the 100th birthday of NHS fundraiser Captain Tom Moore.




apt

Captain Tom Moore sent 125,000 cards for his 100th birthday

A school in Bedfordshire has been flooded with thousands of cards from well wishers across the globe for Captain Tom Moore's upcoming 100th birthday.




apt

Captain Tom Moore's 100th birthday Spitfire flypast WILL go ahead, Grant Shapps insists

Biggin Hill Heritage Hangar said it would instead fly The Spirit of Kent on a circuit around the Biggin Hill airfield at 8pm on Thursday, to coincide with the nation's weekly "Clap for our Carers" event.




apt

War veteran Captain Tom Moore sends thank you message to the UK for well-wishes on eve of 100th birthday

Captain Tom Moore has sent a message to the nation saying he is "completely overwhelmed" by the love he has received ahead of his 100th birthday.




apt

Captain Tom Moore made honorary Colonel to mark 100th birthday as his NHS fundraiser nears £30m

Captain Tom Moore has been appointed as an honorary colonel to mark his 100th birthday after raising almost £30 million for the NHS by walking laps of his garden.




apt

Boris Johnson leads tributes to Captain Tom Moore as nation celebrates 'heroic' war veteran on 100th birthday

Boris Johnson has hailed Captain Tom Moore a "point of light" in the lives of the nation as he led tributes to the war veteran on his 100th birthday.




apt

Nine-year-old with cerebral palsy takes on lockdown marathon challenge inspired by Captain Tom Moore

The nine-year-old was inspired by hero fundraiser Captain Tom Moore's £30 million fundraiser